HORIZON-MISS-2021-CANCER-02-01
HORIZON-MISS-2021-CANCER-02-01
Programme: Horizon Europe
6 projects · €62,411,057 total EU contribution (project-level) · 118 participating organizations · 25 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€62,411,057
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (14)
- BE (10)
- EL (10)
- IL (9)
- Spain (7)
- LT (7)
- France (6)
- Italy (6)
- Netherlands (6)
- CY (5)
- SE (5)
- UK (5)
- PT (4)
- AT (3)
- CH (3)
- DK (3)
- IE (3)
- RO (3)
- BG (2)
- CZ (2)
- HR (1)
- LU (1)
- LV (1)
- SI (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- MEDICAL UNIVERSITY OF GRAZ3 projects · AT
- AINIGMA2 projects · BE
- RESEARCH UNIVERSITY INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS2 projects · EL
- UOA2 projects · EL
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY2 projects · IL
- UKHD2 projects · DE
- UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN2 projects · DE
- SB MARIBOR2 projects · SI
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- accelCH1 projects · CH
- CSIC1 projects · ES
- ARTHUR'S LEGAL1 projects · NL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways ONCOSCREEN · 101097036 | HORIZON | €12,972,076 | €211,250 | Details |
Innovative and safe microwave-based imaging technology to make breast cancer screening more accurate, inclusive and female-friendly MammoScreen · 101097079 | HORIZON | €6,043,547 | €0 | Details |
An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring ThermoBreast · 101096329 | HORIZON | €11,432,044 | €243,750 | Details |
EARLY DYNAMIC SCREENING FOR COLORECTAL CANCER VIA NOVEL PROTEIN BIOMARKERS REFLECTING BIOLOGICAL INITIATION MECHANISMS DIOPTRA · 101096649 | HORIZON | €13,646,551 | €301,250 | Details |
PANcreatic CAncer Initial Detection via liquid biopsy PANCAID · 101096309 | HORIZON | €9,838,840 | €701,906 | Details |
Early detection and screening of hematological malignancies SANGUINE · 101097026 | HORIZON | €8,478,000 | €534,925 | Details |